Neurotechnology Innovation Network Webinar Series | A biodesign approach to Dementia treatment
#Neurotechnology #biodesign #KTNUK #BCIs #Dementia
Featured speakers:
Dr Paul Matthews - Imperial College: 03:46
Dr Richard Perry - Imperial College NHS Healthcare Trust: 30:44
Dr Riona McArdle - Newcastle University: 51:49
Dr Brian Murphy - Brainwave Bank: 01:13:42
Panel discussion: 01:34:00
View and download the slides here: https://www.slideshare.net/KTNUK/neurotechnology-webinar-series-dementia-biodesign
There is growing evidence that technologies such as deep brain stimulation and transcranial magnetic stimulation could help treat some of the effects of dementia and brain-computer interfaces are now able to detect the first signs of dementia years before symptoms appear.
In collaboration with UK Dementia Research Institute, this webinar explores novel neurotechnologies to treat dementia, discuss barriers to adoption and new opportunities in the field.
This webinar is part of a 2-hour monthly series hosted by the Neurotechnology Innovation Network: https://ktn-uk.org/health/neurotechnology/
Each webinar features expert speakers and focusses on a new development in a different technology area. The third topic in this series is Dementia treatment using a biodesign approach. Dementia can have enormous effects, not only to those suffering but also family members and others caring for them, but there are currently no effective therapies available. Neurotechnology offers a new way of treating dementia.
The Neurotechnology Innovation Network will help transfer knowledge from academia to the fast-growing industry sector and will provide a vital meeting place between clinicians and technologists. The aims of this Innovation Network are to grow the neurotechnology community and accelerate innovation through cross-sector collaborations. To keep up to date with events, thought leadership papers and other activities, subscribe to our mailing list: https://r1.dotmailer-surveys.com/9b2vfu0b-5b3wjf3b
_____________________________________________
KTN exists to connect innovators with new partners and opportunities - together we can drive positive change.
Find out more about KTN: https://ktn-uk.org
Follow us on SlideShare to find the slides from all KTN webcasts: https://www.slideshare.net/KTNUK
Subscribe to our YouTube channel to keep up to date with our latest videos: https://www.youtube.com/c/KnowledgeTransferNetwork
Find us on LinkedIn, Twitter & Facebook: @KTNUK #KTNUK #Connecting4Change
#Neurotechnology #biodesign #KTNUK #BCIs #Dementia
Featured speakers:
Dr Paul Matthews – Imperial College: 03:46
Dr Richard Perry – Imperial College NHS Healthcare Trust: 30:44
Dr Riona McArdle – Newcastle University: 51:49
Dr Brian Murphy – Brainwave Bank: 01:13:42
Panel discussion: 01:34:00
View and download the slides here: https://www.slideshare.net/KTNUK/neurotechnology-webinar-series-dementia-biodesign
There is growing evidence that technologies such as deep brain stimulation and transcranial magnetic stimulation could help treat some of the effects of dementia and brain-computer interfaces are now able to detect the first signs of dementia years before symptoms appear.
In collaboration with UK Dementia Research Institute, this webinar explores novel neurotechnologies to treat dementia, discuss barriers to adoption and new opportunities in the field.
This webinar is part of a 2-hour monthly series hosted by the Neurotechnology Innovation Network: https://ktn-uk.org/health/neurotechnology/
Each webinar features expert speakers and focusses on a new development in a different technology area. The third topic in this series is Dementia treatment using a biodesign approach. Dementia can have enormous effects, not only to those suffering but also family members and others caring for them, but there are currently no effective therapies available. Neurotechnology offers a new way of treating dementia.
The Neurotechnology Innovation Network will help transfer knowledge from academia to the fast-growing industry sector and will provide a vital meeting place between clinicians and technologists. The aims of this Innovation Network are to grow the neurotechnology community and accelerate innovation through cross-sector collaborations. To keep up to date with events, thought leadership papers and other activities, subscribe to our mailing list: https://r1.dotmailer-surveys.com/9b2vfu0b-5b3wjf3b
_____________________________________________
KTN exists to connect innovators with new partners and opportunities – together we can drive positive change.
Find out more about KTN: https://ktn-uk.org
Follow us on SlideShare to find the slides from all KTN webcasts: https://www.slideshare.net/KTNUK
Subscribe to our YouTube channel to keep up to date with our latest videos: https://www.youtube.com/c/KnowledgeTransferNetwork
Find us on LinkedIn, Twitter & Facebook: @KTNUK #KTNUK #Connecting4Change
